Exactus, Inc. Appoints Daniel Alberttis to its Board of Directors

DELRAY BEACH, Fla., Jan. 16, 2020 (GLOBE NEWSWIRE) -- Exactus, Inc. (OTCQB:EXDI) (the “Company”), a hemp farmer and manufacturer of hemp-derived phytocannabinoid products, today announced that it has appointed Daniel Alberttis to its Board of Directors.

Emiliano Aloi, President and CEO of Exactus, states, “It is truly a pleasure to have Dan on our Board of Directors. Dan’s extensive experience in high finance and as a corporate advisor will be a perfect fit as we evaluate mergers and acquisitions as well as opportunities to help benefit people in need of our products.”

Daniel Alberttis said, “Exactus has a very bright future ahead and I am excited to bring my experience to the board. With hemp-derived phytocannabinoids offering such promising wellness benefits, the highly experienced team put in place and the success of the 2019 harvest, I am confident that Exactus is well positioned to become a global leader in the sector.”

Daniel Alberttis is currently a Managing Director at The Kannico Agency, a global advisory firm focused on the nonprofit and philanthropic sectors based in Delray Beach, Fl. Mr. Alberttis, a member of the firm's executive team, directs the Strategic Philanthropy division and manages client engagements consisting of Corporations, High Net Worth Families and Private Foundations. Previously, he held various management roles over the course of 13 years for some of the nation's largest financial institutions with the last 6 as a senior banker at JP Morgan Chase. He has advised and managed assets for hundreds of small and mid-sized businesses and has served in several C-level positions as a trusted consultant. He holds a B.S. degree in Business Administration from Lynn University and an M.B.A from Florida Atlantic University.

To learn more about Exactus, Inc., visit the website at .

About Exactus

Exactus Inc. is dedicated to introducing hemp-derived phytocannabinoid products that meet the highest standards of quality and traceability into mainstream consumer markets. The Company has made investments in farming and has over 200 acres of CBD-rich hemp in Southwest Oregon. The Company is introducing a range of consumer brands, such as Green Goddess Extracts™, Levor Collection™, Phenologie™, Paradise CBD™ and Exactus™.

Hemp is a federally legal type of cannabis plant containing less than 0.3% THC (tetrahydrocannabinol), which is the psychoactive component of the cannabis plant. After over 40 years of prohibition, the Agricultural Improvement Act of 2018, known as the 2018 Farm Bill, legalized hemp at the federal level. Hemp production will be regulated by the United States Department of Agriculture (USDA) and the states. As a result, in 2019 hemp was generally removed from the Controlled Substances Act (CSA) and enforcement by the Drug Enforcement Administration (DEA).

For more information about Exactus: .

Investor Notice

Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks, uncertainties and forward-looking statements described under "Risk Factors" in Item 1A of our most recent Form 10-K for the fiscal year ended December 31, 2018 filed with the Securities and Exchange Commission (the "SEC") on March 29, 2019, and in other periodic and current reports we file with the SEC. If any of these risks were to occur, our business, financial condition, or results of operations would likely suffer. In that event, the value of our securities could decline, and you could lose part or all of your investment. The risks and uncertainties we describe are not the only ones facing us. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. In addition, our past financial performance may not be a reliable indicator of future performance, and historical trends should not be used to anticipate results in the future. See "Safe Harbor" below.

Safe Harbor - Forward-Looking Statements

The information provided in this press release may include forward-looking statements relating to future events or the future financial performance of the Company. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Words such as "anticipates," "plans," "expects," "intends," "will," "potential," "hope" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon current expectations of the Company and involve assumptions that may never materialize or may prove to be incorrect. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties. Detailed information regarding factors that may cause actual results to differ materially from the results expressed or implied by statements in this press release relating to the Company may be found in the Company's periodic and current filings with the SEC, including the factors described in the sections entitled "Risk Factors", copies of which may be obtained from the SEC's website at Any forward-looking statement speaks only as of the date on which such statement is made, and the Company does not intend to correct or update any forward-looking statement, whether as a result of new information, future events or otherwise.

Company Contact:

Andrew Johnson

Chief Strategy Officer

Exactus Inc.

509-999-9695